News Daily News ‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes Yael L. Maxwell June 29, 2018
Presentation The Structural Heart Disease Summit 2018 Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages Presenter: David J. Cohen June 22, 2018
News Conference News The Structural Heart Disease Summit 2018 Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR? Shelley Wood June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use? Presenter: Eberhard Grube, Tamim Nazif, Hemal Gada June 21, 2018
News Daily News Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations Todd Neale June 04, 2018
News Conference News EAS 2018 ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran Yael L. Maxwell May 14, 2018
News Daily News Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG Yael L. Maxwell April 23, 2018
News Daily News Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI Yael L. Maxwell April 04, 2018
News Daily News Same-Day Discharge After Peripheral Interventions Gets Mixed Results in Pilot Study Todd Neale March 22, 2018
News Conference News ACC 2018 iFR Cheaper Than FFR Over Trajectory of 1 Year: DEFINE-FLAIR Analysis Caitlin E. Cox March 10, 2018
News Daily News Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers Yael L. Maxwell January 24, 2018
News Daily News Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis Caitlin E. Cox January 08, 2018
News Daily News Spending More Won’t Necessarily Improve Acute MI Outcomes Todd Neale December 22, 2017
News Daily News It’s Official: Evolocumab Gains Claim for CVD Event Reduction Michael O'Riordan December 04, 2017
News Opinion Editor's Corner TCT 2017 My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self Shelley Wood November 22, 2017
News Daily News EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients L.A. McKeown November 17, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News AHA 2017 Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017
News Conference News AHA 2017 Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many Todd Neale November 11, 2017